C59 - Cerebrovascular Disease III: Acute Ischemic Stroke

Event Time: Sunday April 23, 2017 3:30 pm to 5:30 pm
Topic(s): Cerebrovascular Disease and Interventional Neurology
Director(s): Philip Gorelick MD, MPH, FAAN
Description: Stroke is the fifth leading cause of death and a major cause of adult morbidity. Recent advances in acute ischemic stroke (AIS) management have led to new opportunities to reduce acute stroke morbidity and mortality. In this course we provide an evidence-based update of AIS management via a case-based approach. Case-based principles of AIS diagnosis and management will be illustrated by leading experts in the field who will highlight proper use of intravenous alteplase (tPA) and other medical therapies, and endovascular interventions. This program complements C30: Cerebrovascular Disease I: Prevention and C42: Cerebrovascular Disease II: Hemorrhagic Stroke, but covers independent topics.
Completion Message: Participants should be able to discuss proper application of evidence-based guidance for administration of intravenous alteplase (tPA) in acute ischemic stroke (AIS), discuss proper application of evidence-based guidance of other key medical therapies in AIS, and discuss proper application of endovascular interventions in AIS.
CME Credits: 2
Core Competencies: Medical Knowledge, Patient Care

Ready to register for the 2018 AAN Annual Meeting?

Register Now

Related Courses